Pharmaceutical Research and Manufacturers of America CEO Steve Ubl is treating House Speaker Nancy Pelosi's drug pricing bill like a threat despite doubts that it could make it through the GOP-controlled Senate. “We would like to see a balanced package emerge from the legislative process this year and we’re working both sides of the aisle towards that end," Ubl said.

from Kaiser Health News https://ift.tt/2B5jTyJ

Related Posts:

0 comments:

Post a Comment

Popular Posts